JOSEPH A. MEDLIN

334-***-**** (Cell)

EXPERIENCE

President James 41316, Inc. A construction materials company with

operations in Birmingham, Montgomery, Mobile and NW

Florida.

January 2008 - March 2014 (Sold Business)

Montgomery, AL Generated a 250% return and over six years and then

sold business for 25% profit in March 2014 through more

active financial management and reporting.

. Achieved a compound annual growth rate of 15% in sales

during first four years by adding new product lines and

recalibrating salesforce.

. Streamlined sales territories to improve customer

responsiveness and employee morale.

. Secured significant PR coverage for environmentally

friendly recycled glass and for general operations

techniques.

. Implemented financial management, supply chain management

and human resources systems to improve productivity,

inventory levels and profitability.

. Reduced company debt by 75% and established a new working

capital line with three times the original capacity for

growth of additional locations.

Chief Operating ProEthic Pharmaceuticals. A national $70M specialty

pharmaceutical company.

Officer and July 2006 - November 2007 (company sold to Japanese

entity)

Chief Financial

Officer Implemented operational changes that led to a $2.7 million

improvement (prior year was at a loss) to profitability for

the operating brands and a 30% increase in net sales.

Montgomery, AL Contacted, negotiated and closed a $12 million

credit facility with Merrill Lynch and Oxford Finance

within eight weeks of employment.

. Developed KPI's, streamlined closing processes and created

reporting process for more efficient and productive

management.

. Negotiated the structure of a product license within a $1.2

billion market segment at terms that graduate based on

internal success.

Enhanced media relationships and prepared external

communications.

Implemented new financial controls, upgraded financial

team, and engaged Ernst & Young for audits in preparation

of planned Initial Public Offering.

. Led the development and implementation of the first

operating plans for the company.

Developed international relationships with existing and

prospective business constituents including supply chain,

partnering and investor relationships.

Vice President Altea Therapeutics. An $80 million pre-IPO device

and formulations company.

Finance, IT 2003 - July 2006

& Administration

Solicited, presented, negotiated and closed an equity

transaction that raised $32.8 million in cash to fund

research and development activities (This transaction was

awarded Deal of the Year for being the largest venture

round in the state in 2005.).

Atlanta, GA Secured $7.75 million in leveraged capital to purchase

equipment with GE Capital.

. Negotiated a real estate transaction involving the State

Department of Industry and developer funds of over $34

million with an out-of-pocket cost to the company of $400

thousand.

. Reviewed all corporate legal matters, interfaced with

counsel and negotiated all supply, consulting and service

contracts.

. Managed A/P, A/R, Inventory and other working capital items

to manage corporate cash position.

Finalized a comprehensive license and settlement agreement

with a large international pharmaceutical company.

. Established finance department and completed the initial

financial audit of the company (Ernst & Young) and

subsequent audits.

Joseph A. Medlin

Chief Financial Vision Correction Group. A $15 million medical device

and operations company.

Officer 2001 - 2003 (Lost key operating franchise license.)

Atlanta, GA Generated $4 million in aggregate savings while advancing

research and productivity.

Streamlined annual budgeting process, financial controls,

payroll, accounts payable and month-end closing processes

to increase availability of actionable information.

. Developed and maintained short and long term cash

management models.

. Managed human resources and legal aspects including

successful litigation defense.

. Established new business partnership that generated $750

thousand in new revenues.

. Restructured sales commission model to improve productivity

and employee satisfaction.

Directed licensing, M&A, and strategic planning issues

including securing a partner agreement with Johnson &

Johnson and a license agreement with General Electric.

Developed and maintained relationships with banks, venture

firms and investors as well as managed operating

covenants and reported results to the appropriate

stakeholders.

. Managed the financial reporting process including annual

audits by Ernst & Young.

. Managed critical personnel operations in California, New

York and Georgia.

Director HeadHunter.NET A $48 million publicly traded multi-site job

awareness company.

of Finance 2000 (Company sold.)

Norcross, GA Led the development of a new sales commission

program that resulted in higher quality and satisfaction

for customers and sales force alike while enhancing sales

growth.

Established SEC and financial reporting including completion of

S-1 registration statement, 10K, 10Q and Form 4 documents.

. Served as a principal in developing and executing

communications with the venture investors, board of

directors, public investors and bankers.

Acted as key liaison with outside auditors, legal counsel and

human resources contacts.

. Provided key inputs into acquisition activities in

negotiation, due diligence and implementation phases.

Analyzed financial performance indicators to improve

profitability and valuation.

Directed the treasury management process including creditor

relationships, cash forecasting, investments and working

capital management policies.

Channel FORESIGHT SOFTWARE A developer of ERP manufacturing software

systems.

Program 1999 (Y2K phenomena led to downsizing.)

Manager

Assisted manufacturing clients in identification of critical

functionality in implementation of ERP systems.

Dunwoody, GA Facilitated the development of product functionality

to support customer base.

Identified key benchmarking metrics and constructed a

competitive analysis for product positioning and sales

execution.

Director of CYTRX A publicly traded Phase III stage biotechnology company

Finance 1997 - 1998 (Clinical complications caused reduction to eight

employees.)

and Investor

Relations Developed and executed an investor relations road show

that resulted in a 40% increase in the company's valuation

(NASDAQ).

. Developed plans to support tactical and strategic planning and

business

Norcross, GA partnership initiatives.

Supported cash management function through forecasts, financial

analyses, currency policies and interactions with bankers.

Served in key roles in negotiating with investment bankers,

investors and banks on

divestiture activities, private placements and capital

markets endeavors.

Contributed to the successful divestiture of three company

subsidiaries including taking one subsidiary public.

Joseph A. Medlin

Manager of AGCO CORPORATION A publicly traded $3 billion equipment

manufacturer.

Corporate 1994 - 1997 (Left to pursue higher growth opportunity.)

Planning

Established budgeting process after MBO with ultimate

responsibility for eighteen brands in

in 140 different countries.

Developed strategies for increasing dealer sales

through cross-over contracting and product

homologations.

Assisted treasurer in structuring and negotiating $1 billion

multi-currency revolving credit facility.

Duluth, GA Facilitated annual strategic planning process involving

the Board of Directors.

Integrated standard costing components based on overhead

burden, forecasts, component costs, freight, labor, foreign

exchange, product liability and warranty issues for

management of brand profitabilities.

Evaluated financial reporting and budgeting systems.

Handled public relations and investor relations issues

including labor disputes.

. Contributed key inputs into numerous M&A transations

including presentations on target valuation, synergies, and

earnings impact for the board of directors and an array of

investment stakeholders.

Implemented EVA/ROIC methods to evaluate acquisitions and

brand management.

Consultant KURT SALMON ASSOCIATES, INC. A global strategy consulting firm

1993 - 1994 (Excessive travel and AGCO opportunity.)

Atlanta, GA

. Provided consultation to clients on mergers and acquisitions

projects and strategies.

. Assisted clients in developing financial strategies

including cost improvements, budgets, and financial

analysis procedures.

. Advised clients on marketing programs including distribution

strategies and product offerings.

. Served as keynote speaker at industry meetings on M&A trends

and processes.

. Presented engagement proposals and situation assessments to

clients' board of directors and internal and external

stakeholders.

Assistant THE FUJI BANK, LTD. A Japanese bank with approximately $350

billion in assets

Vice President 1989 - 1991 (Left to attend graduate school.)

. Generated $265 million of banking relationships including

credit and hedging instruments.

Atlanta, GA . Developed a strategy for re-negotiating the bank's $115

million share of a $2 billion bankruptcy restructuring

involving 83 institutions from 6 countries.

. Advised Japanese clients on establishing operations within

the U.S.

Analyst METROPOLITAN FEDERAL A savings and loan institution

1987 - 1989 (Left for international opportunities and graduate

school preparation.)

Nashville, TN . Constructed financial models to evaluate project and

loan performance.

. Developed and executed plans to divest foreclosed assets.

EDUCATION

THE UNIVERSITY OF MICHIGAN Ann Arbor, MI

School of Business Administration

Master of Business Administration, May 1993

THE UNIVERSITY OF TENNESSEE Knoxville, TN

College of Business Administration

Bachelor of Science in Business Administration, May 1987

. Major in Finance.

Contact this candidate